Kazia Therapeutics KZIA
NASDAQ KZIA
$9.47 -0.13 (-1.30%)
At close: Oct 1, 2026 · 4:00 PM EDT

Kazia Therapeutics (KZIA) Asset Utilization Ratio (2016)

Updated

Kazia Therapeutics' Asset Utilization Ratio was 0.00 in the year ended Jun 30, 2025, down 96.8% from 0.09 a year earlier.

Analysis

Kazia Therapeutics (KZIA) Asset Utilization Ratio (2016) Analysis & Trends

From the year ended Jun 30, 2009 onward, Kazia Therapeutics has reported Asset Utilization Ratio for 13 years.

  • The figure for the year ended Jun 30, 2025 marks the lowest annual Asset Utilization Ratio since the year ended Dec 31, 2015.
  • Per Business Quant data, Asset Utilization Ratio in earlier years was 0.09 in the year ended Jun 30, 2024 and 0.38 in the year ended Jun 30, 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 0.49
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 0.47
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 0.52
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 0.44
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 0.53
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 0.40
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 0.58
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 0.31
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 0.47
10 Kazia Therapeutics 70.77 Mn 70.77 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2016 0.14
API Access

Kazia Therapeutics Asset Utilization Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=KZIA&period=max&api_key=YOUR_API_KEY